معرفی
Andrew Miranker is a Professor at Yale School of Medicine with primary appointments in the Department of Molecular Biophysics and Biochemistry and secondary affiliation with Chemical and Environmental Engineering. He is affiliated with multiple research centers including the Diabetes Research Center, the High Performance Computation initiative, and the Yale Combined Program in the Biological and Biomedical Sciences (BBS).
His research focuses on protein folding and the formation of amyloid fibrils, particularly in the context of diseases such as type II diabetes and dialysis-related amyloidosis. He investigates systems like islet amyloid polypeptide and beta-2 microglobulin using advanced biophysical techniques including high-field NMR, optical spectroscopy, and electrospray ionization mass spectrometry.
His recent publications highlight interdisciplinary work at the intersection of biophysics, genomics, and data science, including privacy risks in genetic data and the mechanistic roles of metals in amyloid assembly. These works reflect strong collaborations, particularly with Mark Gerstein, and demonstrate a trajectory bridging molecular biophysics with computational and clinical implications.
- Professor, Molecular Biophysics and Biochemistry, Yale School of Medicine
- PhD, Harvard University (1992)
- ORCID: 0000-0003-2267-0630
Dr. Miranker advises graduate students and postdoctoral researchers in molecular biophysics and structural biology. He leads the Miranker Lab, which is actively engaged in both experimental and computational research. There is no mention of external grants or formal mentorship programs in the provided text, but his involvement in major research centers suggests significant research funding and collaborative leadership.
He is a member of interdisciplinary research groups such as Biochemistry, Quantitative Biology, Biophysics and Structural Biology (BQBS), and contributes to Yale Ventures, indicating engagement in translational science and innovation.
